SLC6A3 and Parkinson disease: A direct interaction between α-syn and DAT has been reported in PD patients as well as in experimental models [15,79,249,250,251] (Figure 2B), where it is believed that α-syn controls the trafficking of DAT by modulating the cytoskeleton and DAT anchoring.